{"id":6658,"date":"2017-08-13T07:38:59","date_gmt":"2017-08-13T07:38:59","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/andromedic-esho-2014\/"},"modified":"2026-02-17T10:00:01","modified_gmt":"2026-02-17T10:00:01","slug":"andromedic-esho-2014","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/nl\/andromedic-esho-2014\/","title":{"rendered":"Andromedic interventie ESHO 2014"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/nl\/andromedic-esho-2014\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/nl\/andromedic-esho-2014\/\",\n      \"name\": \"Klinische studies met Andromedic HyDeep 600 WM - ESHO Congres\",\n      \"description\": \"Gegevens van klinische studies met de HyDeep 600 WM voor baarmoederhalskanker en multicenter haalbaarheidsstudies gepresenteerd op het ESHO-congres.\",\n      \"inLanguage\": \"nl-NL\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#website\" },\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"about\": [\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"LACC Cervixcarcinoom Studie\",\n          \"description\": \"Studie bij 8 pati\u00ebnten die 100% lokale controle laat zien bij gebruik van HyDeep 600 WM en HDR-brachytherapie.\",\n          \"studySubject\": { \"@type\": \"MedicalCondition\", \"name\": \"Baarmoederhalskanker\" }\n        },\n        {\n          \"@type\": \"MedicalStudy\",\n          \"name\": \"Spanje Case-Control Studie\",\n          \"description\": \"Grootschalige haalbaarheidsstudie met 293 pati\u00ebnten verdeeld over 9 tumorlocaties.\",\n          \"sampleSize\": 293,\n          \"studyStatus\": \"Published\"\n        }\n      ],\n      \"mentions\": [\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/hyperthermia-doctor-salvatore-conte\/\" },\n        { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n      ]\n    },\n    {\n      \"@type\": [\"Product\", \"MedicalDevice\"],\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\",\n      \"name\": \"HyDeep 600WM\",\n      \"brand\": { \"@type\": \"Brand\", \"name\": \"Andromedic\" },\n      \"image\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/HyDeep-600WM-Andromedic.jpg\",\n      \"description\": \"Geavanceerd oncologisch hyperthermiesysteem \/ professioneel apparaat voor gemoduleerde RF-hyperthermie (13,56 MHz) voor lokale diepe hyperthermie.\",\n      \"offers\": {\n        \"@type\": \"Offer\",\n        \"price\": \"0\",\n        \"priceCurrency\": \"EUR\",\n        \"availability\": \"https:\/\/schema.org\/InStock\",\n        \"url\": \"https:\/\/andromedichyperthermia.com\/nl\/contact\/\",\n        \"priceSpecification\": {\n          \"@type\": \"PriceSpecification\",\n          \"description\": \"Prijs op aanvraag\"\n        }\n      },\n      \"review\": {\n        \"@type\": \"Review\",\n        \"author\": { \"@type\": \"Person\", \"name\": \"Dr. med. Veronica Iatan\" },\n        \"reviewRating\": { \"@type\": \"Rating\", \"ratingValue\": \"5\", \"bestRating\": \"5\" },\n        \"reviewBody\": \"Toonaangevende technologie voor diepe hyperthermie met klinisch gevalideerde protocollen.\"\n      }\n    },\n    {\n      \"@type\": \"MedicalOrganization\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\",\n      \"name\": \"Andromedic Srl\"\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"line-height: 1.6; color: #333; max-width: 1100px; margin: auto; font-family: 'Segoe UI', Helvetica, sans-serif; background-color: #fff; padding: 20px;\">\n<header style=\"border-bottom: 4px solid #1a2a6c; padding-bottom: 25px; margin-bottom: 40px; text-align: center;\">\n<h1 style=\"color: #1a2a6c; font-size: 28px; font-weight: 800; text-transform: uppercase; margin-bottom: 10px;\">European Society for Hyperthermic Oncology: ESHO 2014<\/h1>\n<h2 style=\"color: #b21f1f; font-size: 20px; font-weight: 600;\">Andromedic Interventie \u2013 Dr. Salvatore Conte<\/h2>\n<p style=\"font-size: 16px; max-width: 850px; margin: 15px auto; color: #555;\">Tijdens <a href=\"http:\/\/esho.info\" target=\"_blank\" rel=\"noopener\">ESHO 2014<\/a> kondigde <a href=\"https:\/\/andromedichyperthermia.com\/nl\/hyperthermie-arts-salvatore-conte\/\"><strong>Dr. Salvatore Conte<\/strong><\/a> een belangrijke mijlpaal aan voor het Andromedic hyperthermie-team: de succesvolle productie en levering van 25 <a href=\"https:\/\/andromedichyperthermia.com\/nl\/andromedic-hyperthermie-apparaat\/\"><strong>HyDeep 600WM<\/strong> diepe lokale hyperthermie systemen<\/a> in slechts 18 maanden, met nog eens 40 eenheden bestemd voor India.<\/p>\n<\/header>\n<div style=\"margin-bottom: 50px; border-radius: 15px; overflow: hidden; box-shadow: 0 10px 25px rgba(0,0,0,0.2);\">\n<p><iframe loading=\"lazy\" title=\"intervento Andromedic   Esho 20014\" width=\"640\" height=\"360\" src=\"https:\/\/www.youtube.com\/embed\/fgMdXxoJ1cI?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<\/div>\n<h2 style=\"text-align: center; color: #1a2a6c; margin-bottom: 30px; text-transform: uppercase;\">Gepresenteerde klinische studies: HyDeep 600 WM geavanceerde oncologische hyperthermie<\/h2>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #1a2a6c; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">1. Chemoradiatie + Hyperthermie + HDR Brachytherapie voor LACC<\/h3>\n<\/div>\n<div style=\"padding: 30px; background: #f9f9f9;\">\n<p><strong>DOELSTELLINGEN:<\/strong> Onderzoek naar de resultaten van de combinatie van wekelijkse cisplatine en diepe lokale hyperthermie met IMRT gevolgd door BRT voor lokaal gevorderd cervixcarcinoom (LACC).<\/p>\n<div style=\"background: #fff; padding: 20px; border-radius: 10px; margin: 20px 0; border-left: 5px solid #b21f1f;\">\n<p><strong>MATERIALEN EN METHODEN:<\/strong><\/p>\n<ul style=\"margin-top: 10px; font-size: 15px;\">\n<li><strong>Pati\u00ebntengroep:<\/strong> 8 pati\u00ebnten (3 stadium IIB, 1 IIIB, 2 NEI, 3 LRCC).<\/li>\n<li><strong>Protocol:<\/strong> 50,4 Gy op bekkenklieren met SIB op GTV (61,8 Gy totaal) in 28 fracties. BRT-dosis: 21 Gy in 3 fracties.<\/li>\n<li><strong>Gelijktijdige therapie:<\/strong> Wekelijkse Cisplatine 40mg\/m\u00b2 + HT eenmaal per week.<\/li>\n<\/ul>\n<\/div>\n<div style=\"background: #e8f5e9; padding: 20px; border-radius: 10px; border: 1px solid #2e7d32;\">\n<p><strong style=\"color: #1b5e20; font-size: 17px; display: block; margin-bottom: 10px;\">RESULTATEN &amp; CONCLUSIES:<\/strong><\/p>\n<p style=\"font-size: 16px; font-weight: bold; margin: 0;\">100% LOKALE CONTROLE BEREIKT. Geen behandelingsgerelateerde acute of late graad 3 tot 4 toxiciteit waargenomen.<\/p>\n<p style=\"margin-top: 10px; font-style: italic;\">&#8220;De toevoeging van diepe lokale hyperthermie aan chemoradiotherapie vertegenwoordigt een veelbelovende nieuwe strategie met uitstekende tolerantie.&#8221;<\/p>\n<\/div>\n<\/div>\n<\/section>\n<section style=\"margin-bottom: 50px; border: 1px solid #e1e8ed; border-radius: 15px; overflow: hidden; box-shadow: 0 5px 15px rgba(0,0,0,0.05);\">\n<div style=\"background: #b21f1f; color: #fff; padding: 20px;\">\n<h3 style=\"margin: 0; font-size: 19px;\">2. Quasi Feasibility Studie (Case-Control) \u2013 diepe lokale hyperthermie &#8211; Andalusi\u00eb, Spanje<\/h3>\n<\/div>\n<div style=\"padding: 30px;\">\n<p><strong>Introductie:<\/strong> De eerste klinische studie in Spanje die diepe lokale hyperthermie combineert met standaard kankerbehandelingen binnen het publieke gezondheidssysteem.<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(250px, 1fr)); gap: 20px; margin: 25px 0;\">\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Studie-opzet:<\/strong> Prospectieve, case-control studie. 293 pati\u00ebnten in totaal (97 actieve fase vs. 196 controles). 9 tumorlocaties.<\/div>\n<div style=\"background: #f0f4f8; padding: 15px; border-radius: 10px; border-top: 4px solid #1a2a6c;\"><strong>Behandelparameters:<\/strong> 10 sessies (2-3\/week), duur van 1 uur, 150W\u2013400W met gebruik van het <strong>HyDeep 600WM gemoduleerde hyperthermie apparaat<\/strong>.<\/div>\n<\/div>\n<h4 style=\"color: #1a2a6c; border-bottom: 2px solid #b21f1f; display: inline-block; padding-bottom: 5px;\">Voorlopige gegevens (subgroep van 22 pati\u00ebnten):<\/h4>\n<ul style=\"margin-top: 15px; font-size: 14px; column-count: 2;\">\n<li><strong>Glioblastoom (2c)<\/strong><\/li>\n<li><strong>Hoofd &amp; Nek (7c)<\/strong><\/li>\n<li><strong>Preoperatief Rectum (3c)<\/strong><\/li>\n<li><strong>Borstkanker (3c)<\/strong><\/li>\n<li><strong>Long (NSCLC &#8211; 11c)<\/strong><\/li>\n<li><strong>Prostaat (4c)<\/strong><\/li>\n<li><strong>Cervix &amp; Metastasen<\/strong><\/li>\n<\/ul>\n<div style=\"display: flex; flex-wrap: wrap; gap: 15px; margin: 25px 0;\">\n<div style=\"flex: 1; min-width: 200px; background: #fffde7; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #fbc02d;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">81.2%<\/span><br \/>\n<strong>HOGE TOLERANTIE<\/strong><br \/>\n<small>Pati\u00ebnten tevreden of zeer tevreden<\/small><\/div>\n<div style=\"flex: 1; min-width: 200px; background: #f1f8e9; padding: 20px; border-radius: 10px; text-align: center; border: 1px solid #7cb342;\"><span style=\"font-size: 28px; font-weight: 800; display: block;\">66.6%<\/span><br \/>\n<strong>NUL TOXICITEIT<\/strong><br \/>\n<small>Geen bijwerkingen gerapporteerd<\/small><\/div>\n<\/div>\n<p style=\"background: #f4f7f9; padding: 15px; border-radius: 8px; border-left: 4px solid #1a2a6c;\"><strong>CONCLUSIE:<\/strong> Diepe lokale hyperthermie is haalbaar in de routinezorg van publieke ziekenhuizen zonder buitengewone middelen. Een juiste pati\u00ebntenselectie garandeert minimale (Graad 1) toxiciteit.<\/p>\n<div style=\"text-align: center; margin-top: 30px;\"><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 14px 30px; text-decoration: none; border-radius: 5px; font-weight: 800; text-transform: uppercase; box-shadow: 0 4px 10px rgba(178,31,31,0.3);\" href=\"http:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Protocolo-del-ensayo-MAG-HIP-2013-01-11-EN.pdf\">Download Volledig Studieprotocol (PDF)<\/a><\/div>\n<\/div>\n<\/section>\n<div style=\"margin-top: 40px;\">\n<h3 style=\"text-align: center; color: #1a2a6c; text-transform: uppercase; letter-spacing: 1px;\">ESHO Wetenschappelijke Posters &amp; Documentatie<\/h3>\n<div id='gallery-1' class='gallery galleryid-6658 gallery-columns-1 gallery-size-full'><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/nl\/klinische-proef-hyperthermie\/preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"590\" height=\"837\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg\" class=\"attachment-full size-full\" alt=\"Preliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\" aria-describedby=\"gallery-1-7005\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma.jpg 590w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Preliminary-results-of-chemoradiation-plus-hyperthermia-and-high-dose-rate-brachytherapy-for-locally-advanced-cervical-carcinoma-211x300.jpg 211w\" sizes=\"auto, (max-width: 590px) 100vw, 590px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-7005'>\n\t\t\t\tPreliminary results of chemoradiation plus Andromedic hyperthermia and high dose rate brachytherapy for locally advanced cervical carcinoma\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/nl\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-b\/\"><img loading=\"lazy\" decoding=\"async\" width=\"569\" height=\"831\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg\" class=\"attachment-full size-full\" alt=\"Quasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\" aria-describedby=\"gallery-1-13609\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B.jpg 569w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-B-205x300.jpg 205w\" sizes=\"auto, (max-width: 569px) 100vw, 569px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-13609'>\n\t\t\t\tQuasi feasibility study(case control) asscoaiting deep local hyperthermia treatment with standard cancer treatments and describing patterns of response ESHO\n\t\t\t\t<\/figcaption><\/figure><figure class='gallery-item'>\n\t\t\t<div class='gallery-icon portrait'>\n\t\t\t\t<a href=\"https:\/\/andromedichyperthermia.com\/nl\/quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-2-2\/\"><img loading=\"lazy\" decoding=\"async\" width=\"568\" height=\"826\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg\" class=\"attachment-full size-full\" alt=\"\" aria-describedby=\"gallery-1-10012\" srcset=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response.jpg 568w, https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/02\/Quasi-feasibility-studycase-control-asscoaiting-deep-local-hyperthermia-treatment-with-standard-cancer-treatments-and-describing-patterns-of-response-206x300.jpg 206w\" sizes=\"auto, (max-width: 568px) 100vw, 568px\" title=\"\"><\/a>\n\t\t\t<\/div>\n\t\t\t\t<figcaption class='wp-caption-text gallery-caption' id='gallery-1-10012'>\n\t\t\t\tQuasi feasibility study(case control) associating deep local hyperthermia HyDeep 600WM treatment with standard cancer treatments and describing patterns of response\n\t\t\t\t<\/figcaption><\/figure>\n\t\t<\/div>\n\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>European Society for Hyperthermic Oncology: ESHO 2014 Andromedic Interventie \u2013 Dr. Salvatore Conte Tijdens ESHO 2014 kondigde Dr. Salvatore Conte een belangrijke mijlpaal aan voor het Andromedic hyperthermie-team: de succesvolle productie en levering van 25 HyDeep 600WM diepe lokale hyperthermie systemen in slechts 18 maanden, met nog eens 40 eenheden bestemd voor India. Gepresenteerde klinische&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17356,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template-gutentor-full-width.php","meta":{"footnotes":""},"class_list":["post-6658","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages\/6658","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/comments?post=6658"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/pages\/6658\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/media\/17356"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/nl\/wp-json\/wp\/v2\/media?parent=6658"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}